Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone.

[1]  Daeui Park,et al.  Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. , 2016, Bioorganic & medicinal chemistry letters.

[2]  R. Tripathi,et al.  Exploration of a Library of 3,4‐(Methylenedioxy)aniline‐Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation , 2016, ChemMedChem.

[3]  G. Zengin,et al.  Evaluation of antioxidant, enzyme inhibition, and cytotoxic activity of three anthraquinones (alizarin, purpurin, and quinizarin) , 2016, Human & experimental toxicology.

[4]  S. Ignacimuthu,et al.  Larvicidal and Pupicidal Activities of Alizarin Isolated from Roots of Rubia cordifolia Against Culex quinquefasciatus Say and Aedes aegypti (L.) (Diptera: Culicidae) , 2016, Neotropical Entomology.

[5]  N. Denora,et al.  Searching for Multi-Targeting Neurotherapeutics against Alzheimer’s: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif , 2016, Molecules.

[6]  Jintae Lee,et al.  Calcium-chelating alizarin and other anthraquinones inhibit biofilm formation and the hemolytic activity of Staphylococcus aureus , 2016, Scientific Reports.

[7]  B. N. Sinha,et al.  Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis. , 2016, ACS medicinal chemistry letters.

[8]  I. Orhan.  Potential of Natural Products of Herbal Origin as Monoamine Oxidase Inhibitors. , 2015, Current pharmaceutical design.

[9]  S. Nam,et al.  Inhibition of Monoamine Oxidase by Anithiactins from Streptomyces sp. , 2015, Journal of microbiology and biotechnology.

[10]  A. Ganesan,et al.  cis‐cyclopropylamines as mechanism‐based inhibitors of monoamine oxidases , 2015, The FEBS journal.

[11]  J. P. Petzer,et al.  Indanones As High‐Potency Reversible Inhibitors of Monoamine Oxidase , 2015, ChemMedChem.

[12]  T. Huh,et al.  Purpurin inhibits adipocyte-derived leucine aminopeptidase and angiogenesis in a zebrafish model. , 2014, Biochemical and biophysical research communications.

[13]  C. Sonesson,et al.  A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. , 2014, European journal of medicinal chemistry.

[14]  B. Harvey,et al.  The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase. , 2014, Toxicology and applied pharmacology.

[15]  C. Parsons,et al.  Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease , 2013, Neurotoxicity Research.

[16]  R. Ramsay.  Inhibitor design for monoamine oxidases. , 2013, Current pharmaceutical design.

[17]  M. Rejžek,et al.  Application of a Novel Microtitre Plate-Based Assay for the Discovery of New Inhibitors of DNA Gyrase and DNA Topoisomerase VI , 2013, PloS one.

[18]  Hamed I. Ali,et al.  Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors. , 2012, Journal of medicinal chemistry.

[19]  R. Ramsay.  Monoamine oxidases: the biochemistry of the proteins as targets in medicinal chemistry and drug discovery. , 2012, Current topics in medicinal chemistry.

[20]  S. Vilar,et al.  Monoamine oxidase inhibitors: ten years of docking studies. , 2012, Current topics in medicinal chemistry.

[21]  S. Avnet,et al.  The natural compound Alizarin as an osteotropic drug for the treatment of bone tumors , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[22]  A. Clarke,et al.  Identification of the First Known Inhibitors of O‐Acetylpeptidoglycan Esterase: A Potential New Antibacterial Target , 2012, Chembiochem : a European journal of chemical biology.

[23]  Irene Bolea,et al.  Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. , 2011, Journal of medicinal chemistry.

[24]  K. Kang,et al.  Novel antifungal activity of purpurin against Candida species in vitro. , 2010, Medical mycology.

[25]  K. Hasumi,et al.  Purpurin as a specific inhibitor of spermidine-induced autoactivation of the protease plasma hyaluronan-binding protein. , 2010, Biological & pharmaceutical bulletin.

[26]  Gene-Jack Wang,et al.  Reversible Inhibitors of Monoamine Oxidase-A (RIMAs): Robust, Reversible Inhibition of Human Brain MAO-A by CX157 , 2010, Neuropsychopharmacology.

[27]  P. Renard,et al.  3-[5-(4,5-dihydro-1H-imidazol-2-yl)-furan-2-yl]phenylamine (Amifuraline), a promising reversible and selective peripheral MAO-A inhibitor. , 2006, Journal of medicinal chemistry.

[28]  Keith F. Tipton,et al.  The therapeutic potential of monoamine oxidase inhibitors , 2006, Nature Reviews Neuroscience.

[29]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[30]  C. H. Cheng,et al.  Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. , 2004, Journal of ethnopharmacology.

[31]  T. Gunnlaugsson,et al.  Detecting microdamage in bone , 2003, Journal of anatomy.

[32]  E. Takahashi,et al.  Preventive effects of anthraquinone food pigments on the DNA damage induced by carcinogens in Drosophila. , 2001, Mutation research.

[33]  M. Trivedi,et al.  Meta-Analysis of the Reversible Inhibitors of Monoamine Oxidase Type A Moclobemide and Brofaromine for the Treatment of Depression , 1999, Neuropsychopharmacology.

[34]  H. Chiang,et al.  Inhibition of xanthine oxidase by hydroxylated anthraquinones and related compounds. , 1997, Anticancer research.

[35]  Z. Rong-liang,et al.  Phenolic compounds and an analog as superoxide anion scavengers and anti oxidants , 1991 .

[36]  T. Hergueta,et al.  Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects. , 1990, British journal of clinical pharmacology.

[37]  Lee Chi Hoon,et al.  Antifungal Property of Dihydroxyanthraquinones Against Phytopathogenic Fungi , 2005 .

[38]  R. Ramsay,et al.  Inhibition of Monoamine Oxidase A by β-Carboline Derivatives , 1997 .

[39]  D. Barnard,et al.  Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. , 1992, Antiviral research.